Ch. 22 Pulmonary Infections

  1. Treatment of infections with a antimicrobial agent, such as the penecillins.
    Antibiotic Therapy
  2. Organisms in the group Legionella species, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.
    Atypical Pathogens
  3. Acute inflammation of the lungs contracted from the environment (as distinguished from Nosocomial, or hospital-acquired pneumonia)
    Community-acquired pneumonia
  4. Nonliving material, such as bad linens, or equipment, which may transmit pathogenic organisms to a person who comes into contact with the object.
  5. Pneumonia occurring in any patient hospitalized for 2 or more days in the past 90 days in a acute setting or who, in the past 30 days, has resided in a long-term care or nursing facility, attended a hospital or hemodialysis clinic, or who has received intravenous antibiotics , chemotherapy, or wound care.
    Health care-associated pneumonia (HCAP)
  6. Lower respiratory tract infection that develops in hospitalized patients more then 48 hours after admission and excludes community-acquired infections that are incubating at the time of admission.
    Hospital-acquired pneumonia (HAP)
  7. Any infectious disease of the left and right bronchi and the alveoli.
    Lower respiratory tract infection
  8. Infection acquired after hospitalization. Also called hospital-acquired infections.
    Nosocomial infection
  9. Inflammatory process of the lung parychyma, usually infectious in origin
  10. Chronic granulomatous infection caused by a acid-fast bacillus, Mycobacterium tuberculosis. It is generally transmitted by the inhalation or ingestion of infected droplets and usually affects the lungs, although infection of multiple organ systems occurs.
  11. Lower respiratory tract infection that develops more than 48 to 72 hours after endotracheal intubation
    Ventilator-associated pneumonia
Card Set
Ch. 22 Pulmonary Infections
resp. therapy terminology